OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!


Stage II

In Stage II ovarian cancer, cancer cells have spread from one or both ovaries to other tissues in the pelvis. Cancer cells are found on the fallopian tubes, the uterus, or other tissues in the pelvis. Cancer cells may be found in fluid collected from the abdomen.

    • IIA – Extension or implants onto the uterus and/or fallopian tube. The washings are negative washings and there is no ascites.


    • IIB – Extension or implants onto other pelvic tissues. The washings are negative and there is no ascites.


  • IIC – Pelvic extension or implants like Stage IIA or IIB but with positive pelvic washings

Stage II ovarian cancer is a small group, compromising 10% of ovarian cancer diagnoses.

Prognosis & Survival Rates
For all types of ovarian cancer taken together, about 3 in 4 women with ovarian cancer live for at least 1 year after diagnosis. Almost half (46%) of women with ovarian cancer are still alive at least 5 years after diagnosis. Women diagnosed when they are younger than 65 do better than older women.

Most women diagnosed with Stage II ovarian cancer have a five-year survival rate of approximately 66%. Survival rates are often based on studies of large numbers of people, but they can’t predict what will happen in any particular person’s case. Other factors impact a woman’s prognosis, including her general health, the grade of the cancer, and how well the cancer responds to treatment.


Relative 5-Year Survival Rate









Source:American Cancer Society

Treatment for Stage II ovarian cancer includes: hysterectomy and bilateral salpingo-oophorectomy (removal of both ovaries and fallopian tubes), debulking of as much of the tumor as possible, and sampling of lymph nodes and other tissues in the pelvis and abdomen that are suspected of harboring cancer. After the surgical procedure, treatment may be one of the following: 1) combination chemotherapy with or without radiation therapy or 2) combination chemotherapy.

Your Name (required)

Your Email (required)

Zip Code